EGFR and glioblastoma: Frequent and diagnostically relevant molecular alterations in IDH-wildtype glioblastomas include TERT promoter mutations, EGFR gene amplification, and copy number gain in chromosome 7 combined with copy number loss in chromosome 10 (+7/−10 genotype) [26].